Top news of the week: 04.04.2023.
Current Climate: Pope Francis’ Charge To Create A Sustainable Economy
This week’s Current Climate, which every Saturday brings you the latest news about the business of sustainability.
A brain drug developer joins a growing list of biotech layoffs
California-based Alector plans to reduce its headcount by around 30 as part of a larger effort to reprioritize research programs.
Digital WuXi Global Forum 2023
Dear Colleagues and Friends, Thanks to the wonderful support from so many of you, WuXi AppTec’s in-person WuXi Global Forum 2023, hosted in January during the J.P. Morgan Healthcare ...
Timmerman Traverse for Life Science Cares is Back
The next biotech team adventure is here. I’m thrilled to announce the Timmerman Traverse for Life Science Cares 2023. We’re on a mission to raise $1 million. We’re giving it all back to the ...
Mathai Mammen, former J&J executive, to become FogPharma CEO
The veteran pharmaceutical executive was J&J’s head of R&D until his departure last August. He’s agreed to run FogPharma, a richly funded startup, and take over for founder Greg Verdine.
Gene therapy startup Vedere to close two years after launch
The startup, a successor to an eye gene therapy biotech that Novartis bought in 2020, will wind down after preclinical experiments didn’t meet the bar set by its leaders.
StockWatch: COPD Data, Analysts, Treg Cell Therapy Deal Lift Regeneron
Regeneron Pharmaceuticals shares rose 10% following positive Phase III data for Dupixent® in chronic obstructive pulmonary disease (COPD).
BioNTech moves into ADCs with Duality deal
The biotech is expanding its cancer medicine pipeline by licensing two experimental antibody drug conjugates from Shanghai-based Duality.